Incremental predictive value of red cell distribution width for 12-month clinical outcome after acute myocardial infarction

Clinical Cardiology

Volumn 36, Issue 6, 2013, Pages 336-341

  Lee, Jang Hoon ^a   Yang, Dong Heon ^a   Jang, Se Yong ^a   Choi, Won Suk ^a   Kim, Kyun Hee ^a   Lee, Won Kee ^b   Bae, Myung Hwan ^a   Park, Hun Sik ^a   Cho, Yongkeun ^a   Chae, Shung Chull ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; CREATININE BLOOD LEVEL; DISEASE DURATION; ERYTHROCYTE PARAMETERS; FEMALE; HEART DEATH; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREDICTIVE VALUE; PROGNOSIS; RED CELL DISTRIBUTION WIDTH; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; ERYTHROCYTE INDICES; FEMALE; HEMOGLOBINS; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84879112267     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22114     Document Type: Article

References (28)

1. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001; 345: 1230-1236.
2. Lee PC, Kini AS, Ahsan C, et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2004; 44: 541-546.
3. Reinecke H, Trey T, Wellmann J, et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J. 2003; 24: 2142-2150.
4. Choi DJ, Han S, Jeon ES, et al.; KorHF Registry. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure Registry. Korean Circ J. 2011; 41: 363-371.
5. Felker GM, Allen LA, Pocock SJ, et al.; CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from CHARM Program and the Duke Databank for Cardiovascular Disease. J Am Coll Cardiol. 2007; 50: 40-47.
6. Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010; 105: 312-317.
7. Nabais S, Losa N, Gaspar A, et al. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes. Rev Port Cardiol. 2009; 28: 905-924.
8. Tonelli M, Sacks F, Arnold M, et al.; for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008; 117: 163-168.
9. Lee JH, Park HS, Chae SC, et al.; Korea Acute Myocardial Infarction Registry Investigators. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol. 2009; 104: 182-189.
10. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000; 21: 1502-1513.
11. Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15: 361-387.
12. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated ROC-curves: a non-parametric approach. Biometrics. 1988; 443: 837-845.
13. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27: 157-172.
14. Brightwell RF, Crawford GP, Cale JB, et al. Ageing and the haematological profiles of an Australian community. Ann Hum Biol. 1998; 25: 1-10.
15. Roberts GT, El Badawi SB,. Red blood cell distribution width index in some hematologic diseases. Am J Clin Pathol. 1985; 83: 222-226.
16. Fossat C, David M, Harle JR, et al. New parameters in erythrocyte counting. Value of histograms. Arch Pathol Lab Med. 1987; 111: 1150-1154.
17. Ozkalemkas F, Ali R, Ozkocaman V, et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer. 2005; 5: 144.
18. Spell DW, Jones DV Jr, Harper WF, et al. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prevent. 2004; 28: 37-42.
19. McCord JM,. Iron, free radicals, and oxidative injury. Semin Hematol. 1998; 35: 5-12.
20. Yeun JY, Kaysen GA,. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens. 2000; 9: 621-630.
21. Emdin M, Passino C, Michelassi C, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001; 22: 1802-1807.
22. Chiari MM, Bagnoli R, De Luca PD, et al. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc. 1995; 43: 767-771.
23. Pierce CN, Larson DF,. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005; 20: 83-90.
24. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988; 167: 1211-1227.
25. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113: 1271-1276.
26. Mahu JL, Leclercq C, Suquet JP,. Usefulness of red cell distribution width in association with biological parameters in an epidemiological survey of iron deficiency in children. Int J Epidemiol. 1990; 19: 646-654.
27. Felker GM, Adams KF Jr, Gattis WA, et al. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004; 44: 959-966.
28. Kim HC,. Clinical utility of novel biomarkers in the prediction of coronary heart disease. Korean Circ J. 2012; 42: 223-228.